The SEC should halt this stock immediately before insiders are allowed to enrich themselves even more as the company continues to deceive investors.

This is part 1 of a 2 part series. Citron will not discuss the science behind PolarityTE in this report because it is irrelevant. Once an SEC investigation commences, we expect all the “figureheads” who have prostituted their names for S-8 stock to immediately lawyer up and scatter like cockroaches.

For those of you unfamiliar with the story here is the pitch in two lines: PolarityTe is a development stage company that has developed revolutionary wound care treatments through the intellectual property of a group of John Hopkins doctors. This intellectual property was acquired by a group of serial stock promoters and comes in the form of a patent application. Think of Mimedx with no sales.

Premeditated Securities Fraud?